Latest News
Feature
Biogen plans to submit application to FDA for Alzheimer’s drug aducanumab
The company’s hopes lie with a secondary analysis of high-dose patients from two failed trials.
From the Journals
Soccer pros may face increased risk of death from neurodegenerative disease
Mortality associated with neurodegenerative disease was higher, and mortality associated with other causes lower, among former pro soccer players...
Conference Coverage
Certain diabetes drugs may thwart dementia
COPENHAGEN – Intriguing findings from a Danish national registry study.
Conference Coverage
EEG asymmetry predicts poor pediatric ECMO outcomes
ST. LOUIS – Researchers said “we need to look more closely into brain blood flow patterns” on extracorporeal membrane oxygenation.
Conference Coverage
Next-generation sequencing can shed light on neuropathy etiology
AUSTIN, TEX. – Researchers also found 81 variants of unknown significance in patients, and suggested some could be...
Latest News
Inspector General: NIH must improve conflict of interest reviews
The staff of NIH Institutes and Centers applied inconsistent levels of scrutiny to each other.
Conference Coverage
Primary periodic paralysis attacks reduced with long-term dichlorphenamide
AUSTIN, TEX. – The majority of paresthesia and cognition-related adverse events were mild or moderate with few participants discontinuing the...
Conference Coverage
Patients with Charcot-Marie-Tooth disease describe wide range of care
AUSTIN – An interim analysis examines the use of physical therapy, surgery, medications, orthoses, and walking aids in more than 400 adults with...
Conference Coverage
Researchers identify common reasons for misdiagnosis of ALS
AUSTIN – Particular clinical presentations and cognitive biases are associated with misdiagnosis of patients who...
Conference Coverage
Which patients are most likely to have a positive RNS test for myasthenia gravis?
AUSTIN, TEX. – The diagnostic yield of the test may be highest in patients with MGFA Class III or higher who are...
Conference Coverage
Study examines utility of repeat outpatient electrodiagnostic testing
AUSTIN, TEX. – Repeat testing for the same indication may not change symptom or disease management in about one-third of cases, a preliminary...